TNDM Earnings & Financial Statements
Tandem Diabetes Care, Inc.
$16.32
+$0.31(+1.94%)
34
Overall
40
Value
18
Tech
44
Quality
Market Cap
$1.11B
Volume
2.88M
52W Range
$12.26 - $29.65
Target Price
$27.27
TNDM earnings and financial statements: Tandem Diabetes Care, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
TNDM Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $1.01B | $940.20M | $747.72M | $801.22M | $702.80M |
| Cost of revenue | $468.72M | $450.63M | $380.03M | $388.23M | $326.58M |
| Operating income | -$187.26M | -$99.13M | -$233.23M | -$92.85M | $22.65M |
| EBITDA | -$172.84M | -$65.76M | -$192.45M | -$72.31M | $34.06M |
| Net income | -$204.71M | -$96.03M | -$222.61M | -$94.59M | $15.57M |
| EPS (diluted) | $-3.04 | $-1.47 | $-3.43 | $-1.47 | $0.24 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $881.11M | $967.66M | $952.66M | $1.05B | $905.14M |
| Total liabilities | $725.94M | $704.56M | $639.03M | $612.84M | $472.02M |
| Shareholders’ equity | $155.17M | $263.10M | $313.63M | $439.95M | $433.11M |
| Cash and equivalents | $90.63M | $69.23M | $58.87M | $172.52M | $71.18M |
| Long-term debt | $425.00M | $414.69M | $398.61M | $406.76M | $305.39M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$9.72M | $24.23M | -$31.81M | $50.46M | $111.36M |
| Capital expenditure | -$19.95M | -$19.23M | -$26.80M | -$34.10M | -$23.51M |
| Free cash flow | -$29.67M | $4.99M | -$58.61M | $16.37M | $87.85M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TNDM | $16.32 | +1.9% | 2.88M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Tandem Diabetes Care, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW